• Home
  • Journal
  • Mergers And Acquisitions
  • Immune Thrombocytopenia (ITP) Market to reach USD 3.33 Billion by 2026, Increasing Number of Company Mergers to Aid Growth, says Fortune Business Insights

Immune Thrombocytopenia (ITP) Market to reach USD 3.33 Billion by 2026, Increasing Number of Company Mergers to Aid Growth, says Fortune Business Insights

Pune, Nov. 26, 2019 (GLOBE NEWSWIRE) — The global Immune Thrombocytopenia Market is likely to derive growth from recent advancements in treatment methods of the disease. According to a report published by Fortune Business Insights, titled “ Immune Thrombocytopenia Market Size, Share & Industry Analysis, By Type (Acute Immune Thrombocytopenia, and Chronic Immune thrombocytopenia), By Treatment (Thrombopoietin Receptor Agonist, Immunoglobulins, Corticosteroids, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others) and Regional Forecast, 2019-2026,” the market was valued at USD 2.99 Billion in 2018, and is projected to reach USD 3.33 Billion by 2026, exhibiting a CAGR of 0.54% during the forecast period.Immune thrombocytopenia is a serious blood disorder that occurs due to physical injuries, infections, deficiencies, and other wounds. The adverse effects of the disease have led to a high emphasis on the research and development of newer drugs and therapeutic procedures associated with the treatment of the disease. Growing emphasis on R&D will attract huge investments and yield better products. The increasing number of product launches, coupled with advancements in betterment of existing products will have a direct impact on the growth of the market tin the coming years. Although there are very few options available for treatment of the disease, advancements in ongoing clinical trials have shown promise.
Browse Complete Report Details with Table of Content and Figures:

https://www.fortunebusinessinsights.com/industry-reports/immune-thrombocytopenia-itp-market-101682

The report segments the market based on disease type, treatment type, and regional demographics. Several aspects of the market have been discussed in detail, with focus on growth drivers, leading product types, and major companies. The report highlights key companies that are operating in the market and projects companies that are likely to lead the market in the coming years. Besides this, forecast figures of the market have been drawn through extensive research analysis methods, for the period of 2019-2026.
North America to Emerge Dominant in the Coming YearsBased on regional demographics, the market has been segmented into North America, Latin America, Europe, the middle East and Africa, and Asia Pacific. Among these regions, the market in North America will witness the highest growth in the coming years, driven by easier access to treatment and favourable reimbursement policies. Additionally, the presence of major market players, improving healthcare infrastructure, and growing awareness of blood disorders will have a positive influence on market growth. The ITP market in North America was valued at USD 1.58 Billion in 2018 and is likely to increase further in the coming years.
Sample PDF  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immune-thrombocytopenia-itp-market-101682


Increasing Number of Mergers and Acquisitions Will Aid Market Growth
The report encompasses several factors that have contributed to market growth in recent years. As a result of healthy market competition, companies are looking to adopt standout business strategies, with a view to establishing a stronghold. The increasing number of merger and acquisitions have accounted for a significant market growth rate. In 2018, Dova Pharmaceuticals announced a collaboration with Shanghai Fosun Pharmaceuticals for the development and distribution of Doptelet in China and Hong Kong. Similarly, Novartis announced the acquisition of oncology and pipeline department of Glaxo Smith Kline plc. The company plans to extend its business across the world and establish a wider customer reach.List of the leading companies that are operating in the Immune Thrombocytopenia Market are:Amgen Inc.Novartis AGRigel Pharmaceuticals, Inc.Dova PharmaceuticalsGrifols S.ACSL LimitedOctapharma AGIntas Pharmaceuticals Ltd.Saol Therapeutics
Speak to Analyst
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/immune-thrombocytopenia-itp-market-101682

Table of Content:
IntroductionResearch ScopeMarket SegmentationResearch MethodologyDefinitions and AssumptionsExecutive SummaryMarket DynamicsMarket DriversMarket RestraintsMarket OpportunitiesKey InsightsPrevalence of Immune Thrombocytopenia for Key Countries, 2018Introduction of New Products / Approvals (by Major Players)Recent Developments Mergers, Acquisitions and PartnershipsPipeline AnalysisPatent AnalysisGlobal Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026Key Findings / SummaryMarket Analysis, Insights and Forecast – By TypeAcute Immune ThrombocytopeniaChronic Immune ThrombocytopeniaMarket Analysis, Insights and Forecast – By TreatmentThrombopoietin Receptor AgonistsImmunoglobulinsCorticosteroidsOthersMarket Analysis, Insights and Forecast – By Distribution ChannelHospital PharmacyRetail PharmacyOthersMarket Analysis, Insights and Forecast – By CountryNorth AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaCompetitive LandscapeStrategic RecommendationsContinued…!!!

Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/immune-thrombocytopenia-itp-market-101682

Browse Related Reports:
Revenue Cycle Management Market Size, Share and Global Trend By Structure (In-house Outsource) By Function (Claims & Denial Management, Medical Coding & Billing, Clinical Documentation Improvement (CDI), Insurance, Others) By Type (Software, Services) and Geography Forecast till 2026ePharmacy Market Size, Share and Global Trend By Product (Over-the-Counter Products, Prescription Medicine) and Geography forecast till 2026Breast Implants Market Size, Share & Industry Analysis, By Product (Breast Implants, Tissue Expanders), By Material (Silicone, Saline), By Procedure (Breast Augmentation, Breast Reconstruction), By End User (Hospitals, Specialty Clinics) and Regional Forecast, 2019 – 2026Next-Generation Sequencing (NGS) Market Size, Share and Global Trend By Type (Products, Instruments & Software, Consumables, Services), By Application (Diagnostics, Research), By End User (Research Institutes, Healthcare Facilities & Diagnostic Centres, Pharmaceutical & Biotechnological Companies, Contract Research Organization) & Geography Forecast till 2026
About us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact us:
Fortune Business Insights Pvt. Ltd. 
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
US :+1-424-253-0390
UK :+44-2071-939123
APAC :+91-744-740-1245
Email: sales@fortunebusinessinsights.com
Website: https://www.fortunebusinessinsights.com